We are live on ! Find out more
GNOM icon

Global X Genomics & Biotechnology ETF
GNOM

68 hedge funds and large institutions have $30.1M invested in Global X Genomics & Biotechnology ETF in 2024 Q4 according to their latest regulatory filings, with 14 funds opening new positions, 19 increasing their positions, 20 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

56% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 9

6% more funds holding

Funds holding: 64 → 68 (+4)

0.65% more ownership

Funds ownership: 10.48% → 11.13% (+0.65%)

5% less repeat investments, than reductions

Existing positions increased: 19 | Existing positions reduced: 20

14% less capital invested

Capital invested by funds: $35.2M → $30.1M (-$5.03M)

Holders
68
Holders Change
+4
Holders Change %
+6.25%
% of All Funds
0.9%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
19
Reduced
20
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
FTUS
Flow Traders U.S.
New York
+$622K
2
Two Sigma Investments
Two Sigma Investments
New York
+$383K
3
IWM
IHT Wealth Management
Illinois
+$242K
4
Citadel Advisors
Citadel Advisors
Florida
+$160K
5
EWM
Executive Wealth Management
Michigan
+$128K

Top Sellers

Rank Fund Capital Flow
1
Lido Advisors
Lido Advisors
California
-$1.51M
2
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$579K
3
Bank of America
Bank of America
North Carolina
-$363K
4
Rockefeller Capital Management
Rockefeller Capital Management
New York
-$205K
5
KF
Krilogy Financial
Missouri
-$164K
Name Holding Trade Value Shares
Change 		Change in
Stake
FFA
51
Founders Financial Alliance
North Carolina
$20.8K -$3.15K -75 -12%
Wells Fargo
52
Wells Fargo
California
$17.2K +$18.7K +444 New
FDCDDQ
53
Federation des caisses Desjardins du Quebec
Quebec, Canada
$13.7K – – –
EDRH
54
Edmond de Rothschild Holding
Switzerland
$12.2K – – –
BC
55
Barrett & Company
Rhode Island
$4.86K – – –
Qube Research & Technologies (QRT)
56
Qube Research & Technologies (QRT)
United Kingdom
$4.38K – – –
ACA
57
Aptus Capital Advisors
Alabama
$3.89K – – –
HI
58
Harbour Investments
Wisconsin
$3.79K – – –
NA
59
NewEdge Advisors
Louisiana
$2.91K – – –
GRP
60
Global Retirement Partners
California
$2.73K +$2.94K +70 New
VWM
61
Venturi Wealth Management
Texas
$1.94K – – –
Fidelity Investments
62
Fidelity Investments
Massachusetts
$1.82K +$1.98K +47 New
T
63
Transce3nd
Texas
$1.02K +$1.09K +26 New
AF
64
Allworth Financial
California
$1.02K – – –
HBW
65
Hazlett, Burt & Watson
West Virginia
$1K – – –
SS
66
Sunbelt Securities
Texas
$967 – – –
RDFA
67
Ritter Daniher Financial Advisory
Ohio
$768 – – –
BBPWM
68
Blue Bell Private Wealth Management
Pennsylvania
$719 – – –
JP Morgan Chase
69
JP Morgan Chase
New York
$1 – – –
Lido Advisors
70
Lido Advisors
California
– -$1.51M -33,469 Closed
Rockefeller Capital Management
71
Rockefeller Capital Management
New York
– -$205K -4,547 Closed
MIM
72
Macroview Investment Management
Maryland
– -$6.04K -134 Closed
RA
73
Rise Advisors
New York
– -$5.63K -125 Closed
NP
74
NorthRock Partners
Minnesota
– -$2.42K -54 Closed
Simplex Trading
75
Simplex Trading
Illinois
– -$1K -44 Closed
1 2
3
4

GNOM Hedge Fund Activity: Q4 2024 in Review

68 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Global X Genomics & Biotechnology ETF (GNOM) for Q4 2024, worth a combined $30.1M — down 14% from $35.2M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new GNOM positions and 9 closed out — a net gain of 5 holders — while 19 added to existing stakes and 20 trimmed.

The largest buyer was Flow Traders U.S., adding an estimated $622K. The largest seller was Lido Advisors, exiting entirely with an estimated $1.51M sold.

  • 68 institutional investors held Global X Genomics & Biotechnology ETF (GNOM) as of Q4 2024, up from 64 in Q3 2024.
  • Funds reported $30.1M of Global X Genomics & Biotechnology ETF stock for Q4 2024, down 14% quarter-over-quarter.
  • 14 funds opened new Global X Genomics & Biotechnology ETF positions in Q4 2024 and 9 closed out, a net change of +5 holders.
  • The largest Global X Genomics & Biotechnology ETF buyer in Q4 2024 was Flow Traders U.S., an estimated $622K added.
  • The largest Global X Genomics & Biotechnology ETF seller in Q4 2024 was Lido Advisors, an estimated $1.51M sold.

Based on aggregated 13F filings for Q4 2024.